Company Overview of Reliance GeneMedix Limited
Reliance GeneMedix Limited, together with its subsidiaries, develops, manufactures, and distributes biotechnology pharmaceuticals. The company’s biosimilars are a generic version of recombinant therapeutic proteins. Its product under development includes EPOSTIM, a erythropoietin alpha that is used as a support therapy for the treatment of acute, chronic, and end-stage renal failure; in cancer-induced and chemotherapy related anemia; in patients undergoing major surgeries; and in AIDS patients on zidovudine treatment. The company is headquartered in Tullamore, Ireland. Reliance GeneMedix Limited is a subsidiary of Reliance Life Sciences BV.
IDA Business & Technology Park
353 5 793 23572
353 5 793 23592
Key Executives for Reliance GeneMedix Limited
Reliance GeneMedix Limited Key Developments
Similar Private Companies By Industry
|The Centre for Human Proteomics||Europe|
|Druggability Technologies Holdings Limited||Europe|
|Elan Capital Corp. Ltd.||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Reliance GeneMedix Limited, please visit www.genemedix.com. Company data is provided by Capital IQ. Please use this form to report any data issues.